|Day Low/High||38.39 / 39.99|
|52 Wk Low/High||24.10 / 46.62|
The medical technology firm's acquisitions are starting to pay off.
Stocks take a pause after Monday's rally. Kythera and Boston Scientific get a lift; GM says it can compete with Tesla.
Let's take a peek at the price action overnight and in the early morning in the more important asset classes. The rundown: S&P futures down 9 handles; Nikkei down 1.15%; European markets down -- a lot of earnings disappointments overnight, including...
R. Tyler Bollhorn, author of 'The Mindless Investor,' names his favorite stocks including Boston Scientific, Molycorp and BlackBerry.
Futures are pointing to a higher open this morning and one standout is online gaming company Zynga. TheStreet's David Peltier has this morning's premarket action from New York.
Model N CEO Zack Rinat talks to TheStreet's Debra Borchardt about his company's successful IPO and customer happiness.
The market is encountering resistance, and the short-term moving averages are overbought.
Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.
A look at the day's most searched trends on the Web, including Toyota after the automaker said it will recall more than 1 million vehicles in the U.S. due to airbag and wiper problems.
Portfolio Mgr. David Peltier invites viewers to his monthly #SU10chat on Twitter.
Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.
Perusing legendary investor Michael Price's 13HF filings is well worth the effort.
Following CEO and CFO stock purchases is a way to gauge of company fortunes.